Your browser doesn't support javascript.
loading
Endogenous Retroviral Elements in Human Development and Central Nervous System Embryonal Tumors.
Doucet-O'Hare, Tara T; Rosenblum, Jared S; Shah, Ashish H; Gilbert, Mark R; Zhuang, Zhengping.
Afiliação
  • Doucet-O'Hare TT; National Cancer Institute, Center for Cancer Research, Neuro-Oncology Branch, Building 37, Room 1000, 37 Convent Drive, Bethesda, MD 20892, USA.
  • Rosenblum JS; National Cancer Institute, Center for Cancer Research, Neuro-Oncology Branch, Building 37, Room 1000, 37 Convent Drive, Bethesda, MD 20892, USA.
  • Shah AH; National Institutes of Neurological Disorders and Stroke (NINDS), Surgical Neurology Branch, Bethesda, MD 20892, USA.
  • Gilbert MR; National Cancer Institute, Center for Cancer Research, Neuro-Oncology Branch, Building 37, Room 1000, 37 Convent Drive, Bethesda, MD 20892, USA.
  • Zhuang Z; National Cancer Institute, Center for Cancer Research, Neuro-Oncology Branch, Building 37, Room 1000, 37 Convent Drive, Bethesda, MD 20892, USA.
J Pers Med ; 11(12)2021 Dec 08.
Article em En | MEDLINE | ID: mdl-34945804
ABSTRACT
Human endogenous retroviruses (HERVs), which are critical to normal embryologic development and downregulated during normal maturation, have been implicated in a variety of cancers. Abnormal persistent production of HERVs has been suggested to play a role in oncogenesis and to confer stem cell properties to cells. We recently demonstrated that the most recently incorporated HERV element (HERV-K HML-2) has been associated with the pathogenesis of the embryonal atypical teratoid rhabdoid tumor (AT/RT), shifting our understanding of embryonal tumor development. HML-2 expression is vital for proper human development and its expression is suppressed via methylation or chromatin remodeling as cells differentiate. We previously found that dysfunctional chromatin remodeling due to loss of SMARCB1 expression induces HML-2 envelope (env) expression, impairing cellular differentiation and migration, and facilitating tumor growth in AT/RT. Epigenetic dysregulation in other embryonal tumors with concomitant expression of stem-cell markers may facilitate HML-2 expression. Future studies could utilize HML-2 as potential diagnostic criteria, use its expression as a treatment biomarker, and investigate the efficacy of therapies targeting cells with high HML-2 expression.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: J Pers Med Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: J Pers Med Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos
...